Literature DB >> 2446321

Azidothymidine: crystal structure and possible functional role of the azido group.

A Camerman1, D Mastropaolo, N Camerman.   

Abstract

The crystal and molecular structures of the anti-acquired immunodeficiency syndrome agent 3'-azido-3'-deoxythymidine (AZT) have been determined by x-ray diffraction. There are two crystallographically independent AZT molecules in the crystal asymmetric unit; they have similar conformations and differ primarily in the glycosyl torsion angle. Comparisons with a hydrated thymidylate structure indicate that the azido group does not significantly affect the gross conformational preference of the molecule. The comparisons also suggest possible functional roles for the azido group in enzyme binding.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2446321      PMCID: PMC299517          DOI: 10.1073/pnas.84.23.8239

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  7 in total

1.  Molecular structure of a deoxyribose-dinucleotide, sodium thymidylyl-(5' yields to 3')-thymidylate-(5') hydrate (pTpT), and a possible structural model for polythymidylate.

Authors:  N Camerman; J K Fawcett; A Cameran
Journal:  J Mol Biol       Date:  1976-11-15       Impact factor: 5.469

2.  Imminent marketing of AZT raises problems.

Authors:  G Kolata
Journal:  Science       Date:  1987-03-20       Impact factor: 47.728

3.  Both 2',3'-dideoxythymidine and its 2',3'-unsaturated derivative (2',3'-dideoxythymidinene) are potent and selective inhibitors of human immunodeficiency virus replication in vitro.

Authors:  M Baba; R Pauwels; P Herdewijn; E De Clercq; J Desmyter; M Vandeputte
Journal:  Biochem Biophys Res Commun       Date:  1987-01-15       Impact factor: 3.575

4.  Administration of 3'-azido-3'-deoxythymidine, an inhibitor of HTLV-III/LAV replication, to patients with AIDS or AIDS-related complex.

Authors:  R Yarchoan; R W Klecker; K J Weinhold; P D Markham; H K Lyerly; D T Durack; E Gelmann; S N Lehrman; R M Blum; D W Barry
Journal:  Lancet       Date:  1986-03-15       Impact factor: 79.321

5.  3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.

Authors:  H Mitsuya; K J Weinhold; P A Furman; M H St Clair; S N Lehrman; R C Gallo; D Bolognesi; D W Barry; S Broder
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

6.  Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.

Authors:  P A Furman; J A Fyfe; M H St Clair; K Weinhold; J L Rideout; G A Freeman; S N Lehrman; D P Bolognesi; S Broder; H Mitsuya
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

7.  Inhibition of reverse transcriptase activity by 2',3'-dideoxythymidine 5'-triphosphate and its derivatives modified on the 3' position.

Authors:  K Ono; M Ogasawara; Y Iwata; H Nakane; T Fujii; K Sawai; M Saneyoshi
Journal:  Biochem Biophys Res Commun       Date:  1986-10-30       Impact factor: 3.575

  7 in total
  13 in total

1.  3'-(1,2,3-Triazol-1-yl)-3'-deoxythymidine analogs as substrates for human and Ureaplasma parvum thymidine kinase for structure-activity investigations.

Authors:  Jay Lin; Vincent Roy; Liya Wang; Li You; Luigi A Agrofoglio; Dominique Deville-Bonne; Tamara R McBrayer; Steven J Coats; Raymond F Schinazi; Staffan Eriksson
Journal:  Bioorg Med Chem       Date:  2010-03-15       Impact factor: 3.641

2.  Structural investigation of protonated azidothymidine and protonated dimer.

Authors:  Blake E Ziegler; Rick A Marta; Michael B Burt; Sabrina M Martens; Jonathan K Martens; Terry B McMahon
Journal:  J Am Soc Mass Spectrom       Date:  2013-12-04       Impact factor: 3.109

3.  Identification of a nucleotide binding site in HIV-1 integrase.

Authors:  R R Drake; N Neamati; H Hong; A A Pilon; P Sunthankar; S D Hume; G W Milne; Y Pommier
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

4.  Structure of the anti-human immunodeficiency virus agent 3'-fluoro-3'-deoxythymidine and electronic charge calculations for 3'-deoxythymidines.

Authors:  N Camerman; D Mastropaolo; A Camerman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

5.  A pseudoreceptor modelling study of the varicella-zoster virus and human thymidine kinase binding sites.

Authors:  P A Greenidge; A Merz; G Folkers
Journal:  J Comput Aided Mol Des       Date:  1995-12       Impact factor: 3.686

Review 6.  Anti-AIDS drug development: challenges and strategies.

Authors:  P Mohan
Journal:  Pharm Res       Date:  1992-06       Impact factor: 4.200

7.  Correlation between preferred sugar ring conformation and activity of nucleoside analogues against human immunodeficiency virus.

Authors:  P Van Roey; J M Salerno; C K Chu; R F Schinazi
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

8.  Changes in drug sensitivity of human immunodeficiency virus type 1 during therapy with azidothymidine, dideoxycytidine, and dideoxyinosine: an in vitro comparative study.

Authors:  T Shirasaka; R Yarchoan; M C O'Brien; R N Husson; B D Anderson; E Kojima; T Shimada; S Broder; H Mitsuya
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

9.  Clicking 3'-azidothymidine into novel potent inhibitors of human immunodeficiency virus.

Authors:  Venkata Ramana Sirivolu; Sanjeev Kumar V Vernekar; Tatiana Ilina; Nataliya S Myshakina; Michael A Parniak; Zhengqiang Wang
Journal:  J Med Chem       Date:  2013-10-28       Impact factor: 7.446

10.  Molecular structures of two new anti-HIV nucleoside analogs: 9-(2,3-dideoxy-2-fluoro-beta-D-threo-pentofuranosyl)adenine and 9-(2,3-dideoxy-2-fluoro-beta-D-threo-pentofuranosyl)hypoxanthine.

Authors:  Y C Liaw; Y G Gao; V E Marquez; A H Wang
Journal:  Nucleic Acids Res       Date:  1992-02-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.